Grand Challenges in Parkinson's Disease
The Role of Inflammation
September 18-19, 2013 Grand Rapids, Michigan
10th International Congress on Mental Dysfunction and Non-Motor Features of Parkinson's Disease & Related Disorders
December 4-7, 2014 Nice, France
Join the 10th International Mental Disorders & Other Non-Motor Features in Parkinson’s disease Congress after several successful years of providing the world’s leading specialists with unparalleled access to the latest discoveries and developments in the study of the etiology and therapy of non-motor features of Parkinson’s disease.
MDPD 2014 is a leading annual educational forum offering a unique opportunity to deliberate on brain diseases and how they contribute to cognitive decline, and to identify the specific psychological markers, biochemical and genetic factors of Parkinson’s dementia and of dementia with Lewy bodies. Join your colleagues and discover the latest developments in our understanding of non motor aspects of the basal ganglia, pathological abnormalities related to PD and the genetic mutations resulting in movement disorders.
MDPD Congresses enable you to network with leading neurologists, psychiatrists, psychologists and other multidisciplinary specialists from around the world and exchange information of take-home value. After a highly successful gathering in Asia, MDPD will be returning to its European roots. Join your colleagues in Nice for four days of sun, fun and unexpected treasures in the capital of the French Riviera.
1-3, Rue de Chantepoulet
P.O. Box 1726
CH-1211 Geneva 1
Tel: +41 22 908 0488
Fax: +41 22 906 9140
27th Annual Parkinson Study Group Symposium on Etiology, Pathogenesis, and Treatment of Parkinson’s Disease and Other Movement Disorders
October 1, 2013 Montreal, Canada
The Parkinson Study Group (PSG), in collaboration with the Huntington Study Group (HSG), Dystonia Study Group (DSG), Tourette Syndrome Study Group (TSSG), Cooperative Ataxia Group (CAG), and Tremor Research Group (TRG), will present the 27th Annual Symposium on Etiology, Pathogenesis, and Treatment of Parkinson’s Disease and Other Movement Disorders on Tuesday, October 1, 2013, at Fairmont The Queen Elizabeth Hotel, in Montreal, Canada. The peer-reviewed program includes both platform and poster presentations.
6th Clinical Trials Conference on Alzheimer’s Disease
November 14-16, 2013 San Diego, California
After the success of CtaD 2012 with more than 650 participants from all around the world and exciting presentations we are looking forward to making CtaD 2013 scientifically and clinically challenging!
Alzheimer’s disease is one of the most important health challenges facing aging populations worldwide. The development of the next generation of Alzheimer’s disease drugs is becoming essential to face up to this challenge. We learned in Monte Carlo of new pathways identified with biomarkers, facilitating novel trial designs for studies of tau-based therapies and other disease-modifying drugs including immunotherapy.
May 26-29, 2013 Banff, Alberta, Canada
The Alberta Prion Research Institute, part of Alberta Innovates Bio Solutions, is proud to host the world's largest international prion research congress, PRION 2013, in Banff, Alberta, Canada from May 26-29, 2013.
Highly-respected researchers, students, postdoctoral fellows, clinicians and policy makers from the neurological and prion fields will gather to focus on what can be done collaboratively to work towards discoveries, diagnostics and treatments for debilitating and often fatal neurological diseases in humans and animals. The knowledge exchange that will take place at PRION 2013 will help to shape the future of prion and protein misfolding research and its application around the world.
90th Annual Conference of the American Congress of Rehabilitation Medicine
Progress in Rehabilitation Research
November 12 – 16, 2013 Orlando, Florida
World Parkinson Congress 2013
3rd World Parkinson Congress (WPC 2013) Montreal, Canada October 1 to 4, 2013
The World Parkinson Congresses provide an international forum for the latest scientific discoveries, medical practices and care initiatives related to Parkinson disease. By bringing physicians, scientists, nurses, rehab professionals, policy advocates, care partners, family members and people with Parkinson's disease together, we aim to create a worldwide dialogue that will help expedite the discovery of a cure and best treatment practices for this devastating disease.
Plans are underway for the third World Parkinson Congress from October 1 - 4, 2013 to be held at the Palais des congrès in Montreal, Canada. The WPC 2013 is on track to be as successful as the first two Congresses but we can only do it with your involvement. The WPC 2013 is more than just a meeting. We hope to leave a legacy behind. When planning each WPC, we work with the local community to raise awareness about and increase the quality of life of people living with Parkinson disease. Please join us and help make this vision a reality in Montreal in 2013.
Music Therapy Advances in Neuro-Disability: Innovations in Research & Practice - International Conference
Friday 7 & Saturday 8 June 2013 London, United Kingdom
This two-day conference offers delegates an opportunity to share knowledge and information on the therapeutic applications of music for those with neuro-disability through acquired or neurodegenerative conditions.
Presentations will focus on evidence-based research and practice in this exciting field. All enquiries should be made in the first instance to:
MUSIC THERAPY ADVANCES IN NEURO-DISABILITY
Royal Hospital for Neuro-disability
West Hill, London
SW15 3SW, UK
Tel: +44 (0) 20 8780 4500 ext. 5140
8th International Congress on Vascular Dementia & The First Cognitive Impairment European
October 17-20, 2013 Athens, Greece
The 8th International Congress on Vascular Dementia & The First Cognitive Impairment European Meeting is a niche meeting that will showcase new developments in the study of dementia. The goal of this highly anticipated gathering is to facilitate a fruitful exchange of knowledge and information between leading clinicians and researchers in the field of vascular dementia.
A central aim of ICVD 2013 is to provide participants with an unparalleled opportunity to deliberate with experts from all over the world on the overlap between the latest developments and Alzheimer’s disease.
The Congress is being held in Athens, Greece, 17-20 October 2013. With a high quality programme and historic Athens providing an unforgettable backdrop, ICVD 2013 is an event that must not be missed.